Quarterly Result30 May 2026, 03:42 pm
TTK Healthcare Approves FY26 Results, ₹10 Dividend
AI Summary
TTK Healthcare Ltd's board approved the audited financial results for the fourth quarter and year ended March 31, 2026. A dividend of ₹10 per equity share (100%) has been recommended, subject to shareholder approval. The board also approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of 5 years and the appointment of M/s Geeyes & Co. as the Cost Auditor for FY 2026-27. The 68th Annual General Meeting is scheduled for July 24, 2026, via video conferencing.
Key Highlights
- Audited financial results for FY26 approved with unmodified Auditors’ Report.
- Dividend of ₹10 per share recommended, pending shareholder approval.
- T T Raghunathan reappointed as Executive Chairman for 5 years.
- Geeyes & Co. appointed as Cost Auditor for FY27, subject to ratification.
- 68th AGM scheduled for July 24, 2026, via video conferencing.
Price Impact
More from TTKHEALTH